INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Dec 13, 2019
Document Date
Dec 11, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
MURPHY ANDREW J